Square 1 Bank Provides $5 Million to iScience Interventional
Square 1 Bank provided a $5 million debt facility to iScience Interventional, Inc., a medical device company specializing in the discovery and development of interventional therapies and procedures targeting ophthalmic diseases.
“iScience is excited to have Square 1 Bank as a partner in providing a wealth of financial services to support our mission,” said Mike Nash, iScience CEO.
James Branski, iScience CFO, added, “The team at Square 1 Bank provided the optimal debt facility to fund our distribution expansion plan and support future product platforms for restoring sight to our patients. They executed flawlessly and expeditiously as we transitioned our financial services to Square 1 Bank.”
“iScience is developing game changing technologies that could redefine the standard of care for patients dealing with ocular disease,” commented Scott Foote, SVP and managing director of Square 1 Bank’s Life Sciences West division. “With their impressive investors and pioneering developments, we’re pleased to add iScience to the roster of innovative companies banking with Square 1.”
Square 1 Bank is a full service commercial bank dedicated to serving the financial needs of the venture capital community and entrepreneurs in all stages of growth and expansion.